Investing Profile

John Yianni

InvestorVC
Partner at Earlybird Venture Capital
Photo of John Yianni, Partner at Earlybird Venture Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
2
€350m
CompanyStageDateRound SizeTotal Raised
Prothea Technologies
Series AApr 2024$13M
$13M
Perfuze
SeedJan 2019$3M
$29M
Co-investors: Anne Portwich (EQT Life Sciences), Daniel O'Mahony (Seroba Life Sciences)